|
Market Research Report
Promising Biotech Companies in Europe
| Published by |
Frost & Sullivan |
| Published |
April, 2009 |
Product code |
85571 |
| Content info |
|
| Price |
|
|
Promising Biotech Companies in Europe published by Frost & Sullivan in April, 2009. This report price starts from US $ 6500.
Abstract
This research service aims to profile some of the promising biotech companies
in Europe across different countries and segments.
Table of Contents
1. INTRODUCTION
Biotechnology Industry - Europe
- Overview
- Research and Development Process
Application Areas
- Protein Therapeutics and Monoclonal Antibodies
- Gene Therapy and Anti Sense
2. PROMISING COMPANIES - PROFILES
Profiles
- Affibody
- Antisoma
- Astex Therapeutics
- Bavarian Nordic
- BioInvent
- Biotage
- Biovitrum
- Crucell
- Flamel Technologies
- GPC Biotech
- Immatics Biotechnologies
- Innogenetics
- Intercytex
- Medigene
- Merial
- NeuroSearch
- Novozymes
- Renovo
- Santaris Pharma
- Sartorius Stedium Biotech
- TopoTarget
- Transgene
- Vernalis
3. CONCLUSION
Future of Biotech in Europe
- Biotechnology Post Recession - How will it Be Affected
4. DECISION SUPPORT DATABASES
Databases Used
- Number of Biotechnology Companies
- Pharmaceutical R&D Expenditure
- EPO Biotechnology Patents
- Government R & D Investment in Biotechnology
- Venture Capital Investment in Biotechnology
|
